The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-chloro-N-(2-(4-(4-methoxyphenylsulfonamido)phenyl)benzo[d]oxazol-5-yl)thiophene-2-sulfonamide ID: ALA4531772
PubChem CID: 155546266
Max Phase: Preclinical
Molecular Formula: C24H18ClN3O6S3
Molecular Weight: 576.08
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(S(=O)(=O)Nc2ccc(-c3nc4cc(NS(=O)(=O)c5ccc(Cl)s5)ccc4o3)cc2)cc1
Standard InChI: InChI=1S/C24H18ClN3O6S3/c1-33-18-7-9-19(10-8-18)36(29,30)27-16-4-2-15(3-5-16)24-26-20-14-17(6-11-21(20)34-24)28-37(31,32)23-13-12-22(25)35-23/h2-14,27-28H,1H3
Standard InChI Key: VPULAWVUCKOWPW-UHFFFAOYSA-N
Molfile:
RDKit 2D
37 41 0 0 0 0 0 0 0 0999 V2000
43.7404 -14.7507 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
43.7445 -13.9335 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
43.0347 -14.3385 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.5602 -12.9595 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.9729 -13.6694 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
36.3813 -12.9570 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.3913 -12.8522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3901 -13.6717 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0982 -14.0807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0964 -12.4433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6821 -14.0797 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.2660 -14.0826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.8050 -12.8486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.8098 -13.6672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.5898 -13.9156 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.0672 -13.2505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.5821 -12.5911 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
40.8844 -13.2457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.2946 -13.9521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.1110 -13.9476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.5162 -13.2370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.0990 -12.5294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.2840 -12.5373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.3334 -13.2311 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
44.5617 -13.9335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5191 -13.7555 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
33.9745 -14.3670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3878 -15.0739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1877 -14.8992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1613 -14.2860 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
44.9684 -14.6435 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.7849 -14.6439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.1943 -13.9356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.7813 -13.2256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.9662 -13.2287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
47.0115 -13.9346 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
47.4210 -14.6417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
5 4 2 0
6 5 2 0
7 8 2 0
8 9 1 0
9 14 2 0
13 10 2 0
10 7 1 0
8 11 1 0
11 5 1 0
5 12 1 0
13 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 13 1 0
16 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
21 24 1 0
24 2 1 0
2 25 1 0
12 26 1 0
26 27 1 0
27 28 2 0
28 29 1 0
29 12 2 0
27 30 1 0
25 31 2 0
31 32 1 0
32 33 2 0
33 34 1 0
34 35 2 0
35 25 1 0
33 36 1 0
36 37 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 576.08Molecular Weight (Monoisotopic): 575.0046AlogP: 5.82#Rotatable Bonds: 8Polar Surface Area: 127.60Molecular Species: ACIDHBA: 8HBD: 2#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 6.12CX Basic pKa: 0.81CX LogP: 4.88CX LogD: 3.97Aromatic Rings: 5Heavy Atoms: 37QED Weighted: 0.24Np Likeness Score: -1.84
References 1. Washburn A, Abdeen S, Ovechkina Y, Ray AM, Stevens M, Chitre S, Sivinski J, Park Y, Johnson J, Hoang QQ, Chapman E, Parish T, Johnson SM.. (2019) Dual-targeting GroEL/ES chaperonin and protein tyrosine phosphatase B (PtpB) inhibitors: A polypharmacology strategy for treating Mycobacterium tuberculosis infections., 29 (13): [PMID:31047750 ] [10.1016/j.bmcl.2019.04.034 ]